Related Experiment Video
Updated: Apr 24, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
22.0K
[Irradiation in stereotactic conditions: prerequisites]
1Département de radiothérapie, centre Georges-François-Leclerc, 1, rue Professeur-Marion, 21034 Dijon cedex, France.
Summary
Stereotactic body radiotherapy indications are increasing. Prioritizing prospective trials and quality assurance is crucial for evaluating extracranial stereotactic body irradiation efficacy and toxicity.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Context:
- Increasing adoption of stereotactic body radiotherapy (SBRT) for new indications.
- Extracranial SBRT lacks long-term data on efficacy and late toxicities.
- Multidisciplinary team validation of SBRT indications is critical.
Purpose:
- To highlight the need for rigorous evaluation of emerging SBRT indications.
- To emphasize the importance of prospective, independent clinical trials.
- To advocate for robust quality assurance programs in SBRT.
Summary:
- The growing use of SBRT necessitates careful validation of treatment indications.
- Emerging extracranial SBRT techniques require long-term outcome and toxicity assessments.
- Prospective trials with strong quality assurance are essential for advancing SBRT knowledge.
Impact:
- Improved selection criteria for SBRT, enhancing patient outcomes.
- Development of evidence-based guidelines for SBRT implementation.
- Ensuring high-quality SBRT delivery and patient safety.
